Glenn Merlino

26.3k total citations · 4 hit papers
215 papers, 17.9k citations indexed

About

Glenn Merlino is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Glenn Merlino has authored 215 papers receiving a total of 17.9k indexed citations (citations by other indexed papers that have themselves been cited), including 141 papers in Molecular Biology, 80 papers in Oncology and 41 papers in Genetics. Recurrent topics in Glenn Merlino's work include Liver physiology and pathology (24 papers), Melanoma and MAPK Pathways (22 papers) and melanin and skin pigmentation (21 papers). Glenn Merlino is often cited by papers focused on Liver physiology and pathology (24 papers), Melanoma and MAPK Pathways (22 papers) and melanin and skin pigmentation (21 papers). Glenn Merlino collaborates with scholars based in United States, Japan and United Kingdom. Glenn Merlino's co-authors include Ira Pastan, Chamelli Jhappan, M. Raza Zaidi, Shunsuke Ishii, Mark C. Willingham, Miriam R. Anver, Bruce H. Howard, Frances P. Noonan, Gilbert H. Smith and Hisashi Takayama and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Glenn Merlino

213 papers receiving 17.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection.

1982 1.3k citations Glenn Merlino et al. profile →
TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas

1990 598 citations Chamelli Jhappan, Gilbert H. Smith et al. profile →
Preclinical Mouse Cancer Models: A Maze of Opportunities and Challenges

2015 453 citations Glenn Merlino, Terry Van Dyke et al. profile →
Hippo-Independent Activation of YAP by the GNAQ Uveal Melanoma Oncogene through a Trio-Regulated Rho GTPase Signaling Circuitry

2014 427 citations Xiaodong Feng, María Sol Degese et al. Cancer Cell profile →

Peers

Countries citing papers authored by Glenn Merlino

Since Specialization

Citations

This map shows the geographic impact of Glenn Merlino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glenn Merlino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glenn Merlino more than expected).

Fields of papers citing papers by Glenn Merlino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glenn Merlino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glenn Merlino. The network helps show where Glenn Merlino may publish in the future.

Co-authorship network of co-authors of Glenn Merlino

This figure shows the co-authorship network connecting the top 25 collaborators of Glenn Merlino. A scholar is included among the top collaborators of Glenn Merlino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glenn Merlino. Glenn Merlino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of Personalized Strategies for Precisely Battling Malignant Melanoma 2024 ·International Journal of Molecular Sciences ·(unknown), G Clements, (unknown), Glenn Merlino, Yanlin Yu	6
2	Stochastic modeling of single-cell gene expression adaptation reveals non-genomic contribution to evolution of tumor subclones 2024 ·Cell Systems ·(unknown), Soumitra Pal, Farid Rashidi Mehrabadi, Salem Malikić, (unknown), Antonella Sassano, Eva Pérez‐Guijarro, Glenn Merlino, S. Cenk Şahinalp, Erin K. Molloy, Chi‐Ping Day, Teresa M. Przytycka	4
3	Ez-Metastasizing: The Crucial Roles of Ezrin in Metastasis 2023 ·Cells ·(unknown), Glenn Merlino, Yanlin Yu	12
4	Fast intratumor heterogeneity inference from single-cell sequencing data 2022 ·Nature Computational Science ·(unknown), Farid Rashidi Mehrabadi, (unknown), Eva Pérez‐Guijarro, Kerrie L. Marie, Maxwell P. Lee, Chi‐Ping Day, Glenn Merlino, Funda Ergün, Aydın Buluç, S. Cenk Şahinalp, Salem Malikić	3
5	Distinct Biomarker Profiles and TCR Sequence Diversity Characterize the Response to PD-L1 Blockade in a Mouse Melanoma Model 2021 ·Molecular Cancer Research ·Rajaâ El Meskini, (unknown), (unknown), (unknown), (unknown), Nathan Pate, (unknown), Michael D. Oberst, Ian M. Kaplan, Patrick Raber, Terry Van Dyke, Shyam K. Sharan, Robert E. Hollingsworth, Chi‐Ping Day, Glenn Merlino, Zoë Weaver Ohler	3
6	PERK mediates resistance to BRAF inhibition in melanoma with impaired PTEN 2021 ·npj Precision Oncology ·Yifei Qin, Qiang Zuo, Lei Huang, Liping Huang, Glenn Merlino, Yanlin Yu	17
7	Synthetic Lethal Screens Reveal Cotargeting FAK and MEK as a Multimodal Precision Therapy for GNAQ -Driven Uveal Melanoma 2021 ·Clinical Cancer Research ·Justine S. Paradis, (unknown), Robert Saddawi‐Konefka, (unknown), Simone Lubrano, (unknown), Nadia Arang, Manoela Tiago, Sílvia Coma, Xingyu Wu, Kyle Ford, Chi‐Ping Day, Glenn Merlino, Prashant Mali, Jonathan A. Pachter, Takami Sato, Andrew E. Aplin, J. Silvio Gutkind	54
8	PhISCS-BnB: a fast branch and bound algorithm for the perfect tumor phylogeny reconstruction problem 2020 ·Bioinformatics ·(unknown), Farid Rashidi Mehrabadi, Salem Malikić, (unknown), Osnat Bartok, Kevin Litchfield, Ronen Levy, Yardena Samuels, Alejandro A. Schäffer, E. Michael Gertz, Chi‐Ping Day, Eva Pérez‐Guijarro, Kerrie L. Marie, Maxwell P. Lee, Glenn Merlino, Funda Ergün, S. Cenk Şahinalp	14
9	Integrated Genomics Identifies miR-32/MCL-1 Pathway as a Critical Driver of Melanomagenesis: Implications for miR-Replacement and Combination Therapy 2016 ·PLoS ONE ·Prasun Mishra, Pravin J. Mishra, Glenn Merlino	18
10	Hippo-Independent Activation of YAP by the GNAQ Uveal Melanoma Oncogene through a Trio-Regulated Rho GTPase Signaling Circuitry breakdown → 2014 ·Cancer Cell ·Xiaodong Feng, María Sol Degese, Ramiro Iglesias‐Bartolomé, José P. Vaqué, Alfredo Molinolo, Murilo Wendeborn Rodrigues, M. Raza Zaidi, Bruce R. Ksander, Glenn Merlino, Akrit Sodhi, Qianming Chen, J. Silvio Gutkind	427
11	Modeling the Transcriptional Consequences of Epidermal Growth Factor Receptor Ablation in Ras-Initiated Squamous Cancer 2011 ·Clinical Cancer Research ·(unknown), Andrew Ryscavage, Glenn Merlino, Stuart H. Yuspa	2
12	Preclinical therapeutic response of residual metastatic disease is distinct from its primary tumor of origin 2011 ·International Journal of Cancer ·Chi‐Ping Day, John Carter, Carrie Bonomi, Melinda G. Hollingshead, Glenn Merlino	25
13	Lack of promoting effects of phenobarbital at low dose on diethylnitrosamine-induced hepatocarcinogenesis in TGF-alpha transgenic mice. 2006 ·PubMed ·(unknown), Masakazu Kakuni, Hideki Wanibuchi, Anna Kinoshita, Jin Seok Kang, Elsayed I. Salim, Keiichirou Morimura, Seiko Tamano, Glenn Merlino, Shoji Fukushima	6
14	Ultraviolet B but not Ultraviolet A Radiation Initiates Melanoma 2004 ·Cancer Research ·Edward C. De Fabo, Frances P. Noonan, Thomas R. Fears, Glenn Merlino	207
15	Lifetime exposure to a soluble TGF-β antagonist protects mice against metastasis without adverse side effects 2002 ·Journal of Clinical Investigation ·Yu-an Yang, Oksana I. Dukhanina, Binwu Tang, Mizuko Mamura, John J. Letterio, Jennifer MacGregor, (unknown), Sean Khozin, Zi-yao Liu, Jeffrey Green, Miriam R. Anver, Glenn Merlino, Lalage M. Wakefield	278
16	Obligate Roles for p16 ^Ink4a and p19 ^Arf -p53 in the Suppression of Murine Pancreatic Neoplasia 2002 ·Molecular and Cellular Biology ·Nabeel Bardeesy, Jeffrey A. Morgan, Manisha Sinha, Sabina Signoretti, Shefali Srivastava, Massimo Loda, Glenn Merlino, Ronald A. DePinho	52
17	NK1, a Natural Splice Variant of Hepatocyte Growth Factor/Scatter Factor, Is a Partial Agonist In Vivo 1998 ·Molecular and Cellular Biology ·John Jakubczak, William J. LaRochelle, Glenn Merlino	48
18	Histochemical Analysis of Hyperplastic Stomach of TGF-alpha Transgenic Mice 1997 ·Digestive Diseases and Sciences ·(unknown), Toshio Fukusato, (unknown), (unknown), Glenn Merlino, Yutaka Tsutsumi	22
19	Ectopic TGFβ1 Expression in the Secretory Mammary Epithelium Induces Early Senescence of the Epithelial Stem Cell Population 1995 ·Developmental Biology ·Edith C. Kordon, Robert A. McKnight, Chamelli Jhappan, Lothar Hennighausen, Glenn Merlino, Gilbert H. Smith	153
20	Pancreatic gastrin stimulates islet differentiation of transforming growth factor alpha-induced ductular precursor cells. 1993 ·Journal of Clinical Investigation ·(unknown), Susan Bonner‐Weir, P. S. Oates, (unknown), Babette Simon, Glenn Merlino, Emmett V. Schmidt, Stephen J. Brand	230

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact